Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Headshot of Igor Kuzmin

Igor A Kuzmin Ph.D.

Program Director, TRP
Division of Cancer Treatment and Diagnosis
Translational Research Program
240-276-5684
|
kuzmini@nih.gov

Igor A. Kuzmin, Ph.D. is a Program Director at the Translational Research Program within the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI). Dr. Kuzmin manages Specialized Programs of Research Excellence (SPOREs) in leukemia, lymphoma, myeloma, skin/melanoma, gastrointestinal and liver cancer.

Prior to his appointment at the NCI, Dr. Kuzmin served as a senior scientist at SAIC-Frederick, Inc., a subsidiary of Science Applications International Corporation that provides research support to various NCI programs. Dr. Kuzmin contributed to identification of several cancer-related genes on human chromosome 3p, including the von Hippel-Lindau disease tumor suppressor gene, RASSF1A, and FUS1. He authored 36 professional publications.

  • Reviewed:
Email